Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)
Constantine S Tam, Susan O'Brien, William Plunkett, William Wierda, Alessandra Ferrajoli, Xuemei Wang, Kim-Anh Do, Jorge Cortes, Issa Khouri, Hagop Kantarjian, Susan Lerner, Michael J Keating
Blood | AMER SOC HEMATOLOGY | Published : 2014
C.S.T. receives honorarium and research funding from Roche. The remaining authors declare no competing financial interests.